News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
831,785 Results
Type
Article (85624)
Company Profile (744)
Press Release (745417)
Section
Business (232263)
Career Advice (4106)
Deals (39645)
Drug Delivery (116)
Drug Development (90661)
Employer Resources (194)
FDA (17979)
Job Trends (17274)
News (395599)
Policy (39621)
Tag
Academia (2975)
Alliances (56462)
Alzheimer's disease (1337)
Approvals (17885)
Artificial intelligence (158)
Bankruptcy (394)
Best Places to Work (12525)
Biotechnology (509)
Breast cancer (131)
Cancer (1182)
Cardiovascular disease (110)
Career advice (3513)
Cell therapy (271)
Clinical research (71552)
Collaboration (420)
Compensation (207)
COVID-19 (2803)
C-suite (106)
Data (1159)
Diabetes (168)
Diagnostics (6683)
Earnings (94756)
Employer resources (167)
Events (126821)
Executive appointments (328)
FDA (18549)
Funding (381)
Gene therapy (204)
GLP-1 (697)
Government (5048)
Healthcare (20719)
Infectious disease (2897)
Inflammatory bowel disease (121)
Interviews (807)
IPO (17598)
Job creations (5179)
Job search strategy (2855)
Layoffs (489)
Legal (10044)
Lung cancer (190)
Manufacturing (202)
Medical device (14414)
Medtech (14419)
Mergers & acquisitions (22100)
Metabolic disorders (473)
Neuroscience (1645)
NextGen Class of 2024 (7657)
Non-profit (5065)
Northern California (1522)
Obesity (271)
Opinion (244)
Patents (112)
People (64191)
Pharmaceutical (148)
Phase I (22020)
Phase II (31075)
Phase III (23423)
Pipeline (470)
Postmarket research (3540)
Preclinical (9960)
Radiopharmaceuticals (259)
Rare diseases (247)
Real estate (7373)
Regulatory (25968)
Research institute (2642)
Resumes & cover letters (648)
Southern California (1347)
Startups (4276)
United States (14670)
Vaccines (653)
Weight loss (221)
Date
Today (3)
Last 7 days (727)
Last 30 days (3684)
Last 365 days (38568)
2024 (35453)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (228)
Asia (49350)
Australia (8697)
California (3545)
Canada (1315)
China (267)
Colorado (159)
Connecticut (173)
Europe (113033)
Florida (476)
Georgia (127)
Illinois (418)
Indiana (216)
Kansas (103)
Maryland (631)
Massachusetts (2866)
Michigan (179)
Minnesota (299)
New Jersey (1010)
New York (1007)
North Carolina (844)
Northern California (1522)
Ohio (149)
Pennsylvania (873)
South America (1647)
Southern California (1347)
Texas (513)
Washington State (403)
There are 831,785 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Antibody-drug conjugate
Next-Gen ADCs Driving ‘Renaissance’ in Already Hot Oncology Drug Class
ADC Therapeutics, Sutro Biopharma and Zai Lab are among those developing antibody-drug conjugates to address payload and toxicity challenges of current ADCs—and rapidly grow the multi-billion-dollar market.
November 25, 2024
·
7 min read
·
Greg Slabodkin
Business
Embattled Sage Dealt Deeper Blow With Huntington’s Failure
Sage Therapeutics discontinued development of its lead candidate dalzanemdor after a third clinical failure, leading analysts to question the biotech’s future profitability.
November 25, 2024
·
4 min read
·
Heather McKenzie
Regulatory
FDA Action Alert: Applied Therapeutics Awaits Verdict on Rare Disease Therapy
With two decisions originally scheduled for this week already announced, including BridgeBio’s approval in ATTR-CM, the regulator has just one PDUFA on its plate this holiday week.
November 25, 2024
·
1 min read
·
Tristan Manalac
Drug Development
BridgeBio Wins FDA Approval for ATTR-CM Drug, Launching Competition With Pfizer
BridgeBio secured approval for Attruby Friday, along with the all-important mortality benefit that could give the drug a significant boost in the market against Pfizer’s tafamidis and potentially Alnylam’s Amvuttra.
November 23, 2024
·
8 min read
·
Heather McKenzie
Press Releases
Stonegate Updates Coverage on Burcon Nutrascience Corporation (BU) FY25 Q2
November 22, 2024
·
1 min read
Press Releases
Oncology Clinical Trials Market Size Expected to Reach USD 22.11 Bn by 2033
November 22, 2024
·
1 min read
Press Releases
Sartorius Stedim Biotech opens new Center for Bioprocess Innovation in Marlborough, USA
November 22, 2024
·
3 min read
Press Releases
TCB Capital Advisors Expands Strategic Advisory Board
TCB strengthens its capital markets and operational advisory businesses with the addition of numerous notable Strategic Advisory Board members from across the healthcare and life sciences sectors
November 22, 2024
·
1 min read
Editorial
Trump’s ‘Team of Self Promoters’ Will Make for Great Reality TV but an Uncertain Biopharma Environment
RFK Jr. as HHS head is perhaps President-elect Donald Trump’s most controversial Cabinet pick now that Matt Gaetz has withdrawn as nominee for Attorney General. With Dr. Oz tapped to lead CMS and maybe Marty Makary at the FDA, it’s going to be quite the show.
November 22, 2024
·
6 min read
·
Jef Akst
Layoff Tracker
Sonata Therapeutics Laying off 20 Employees, Changing Leadership
Follow along as
BioSpace
keeps you up-to-date on the latest pharma and biotech layoffs.
November 22, 2024
·
187 min read
·
BioSpace Editorial Staff
1 of 83,179
Next
